CRISPR Therapeutics AG
CRSP News Today: Stay Updated with the Latest CRISPR Therapeutics AG News in Real Time
Find CRSP news now at Meyka AI. Stay informed with the latest CRISPR Therapeutics AG stocks updates, including price news, market analysis, and expert insights.
ALNA stock drops 99% since IPO, trades at $0.075 on NASDAQ
ALNA stock trades at $0.075 with 252M volume. Allena Pharmaceuticals faces severe losses and declining valuations in biotech sector.
SURE.CN Stock Surges 1.85% on Volume Spike, 25 Apr 2026
SURE.CN stock rises 1.85% with volume spike to 803,263 shares. SureNano Science trades at C$0.275 on CNQ exchange.
ADXN.SW Stock Surges 8.7% as Addex Therapeutics Nears Earnings
ADXN.SW stock jumps 8.7% to CHF0.0498 on SIX ahead of April 27 earnings. Biotech firm faces profitability challenges but shows momentum.
RLF.SW Stock Bounces 0.87% on April 24 as Biotech Finds Support
Relief Therapeutics (RLF.SW) rises 0.87% to CHF 2.885 on SIX. Biotech stock shows oversold bounce signals amid clinical trials.
DFTX Citigroup Positive Rating April 2026
Citigroup initiates Definium Therapeutics (DFTX) with a Positive rating on April 23, 2026, citing psychedelic drug development potential.
TVTX Insider Selling: Chief Research Officer Disposes 9,100 Shares April 24, 2026
TVTX insider William Rote, Chief Research Officer, sold 9,100 shares at $39.09 on April 22, 2026. SEC filing reveals $355,719 transaction.
SGMO Insider Sells 69,827 Shares at $0.25 on April 24, 2026
Sangamo Therapeutics insider Gregory Davis sold 69,827 shares at $0.25 per share on April 22, 2026. SEC Form 4 filing details.
ACRV Insider Buying: RA Capital Acquires 3.89M Shares April 24, 2026
RA Capital Management acquired 3.89M ACRV shares at $1.80 on April 22, 2026. Major insider buying signal for Acrivon Therapeutics.
OBSN.SW Stock Plunges 76.9% in Pre-Market Trading on SIX
OBSN.SW stock crashes 76.9% to CHF0.0012 in pre-market session. ObsEva S.A. biotech faces severe losses amid clinical trials.